Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability

Authors:: Anoop Nambiar; Dean Kellogg III; Jaime Justice; Martin Goros; Jonathan Gelfond; Rodolfo Pascual; Shahrukh Hashmi; Michal Masternak; Larissa Prata; Nathan LeBrasseur; Andrew Limper; Stephen Kritchevsky; Nicolas Musi; Tamara Tchkonia; James Kirkland

Reference:: eBioMedicine; 2023; 90; 104481

DOI:: 10.1016/j.ebiom.2023.104481

See Abstract

Key Words:: Clinical trial phase I; randomization; single blind; placebo controlled; idiopathic pulmonary fibrosis; senolytics; quercetin; dasatinib; adverse events

Back to index